Key Takeaways
Peter Thiel has disclosed a 7.5% stake in ETHZilla, which trades under the ticker ATNF.
Thiel and his investor group reported beneficial ownership of over 11 million shares of 180 Life Sciences.
Peter Thiel, the billionaire tech investor and co-founder of PayPal and Palantir, is part of an investor group that holds a 7.5% stake in 180 Life Sciences, which is rebranding as ETHZilla, an Ethereum-focused corporate treasury vehicle, according to a new SEC disclosure.
Shares of 180 Life Sciences (ATNF) jumped over 11% at Monday’s close and surged roughly 57% in overnight trading, Yahoo Finance data shows.
180 Life Sciences announced its Ethereum treasury plan in late July.
On Monday, the biotech firm said it sold $156 million in senior secured convertible notes due 2028 to an institutional investor, following a recent $425 million private placement. Proceeds will primarily fund Ethereum purchases, yield-bearing assets, and the company’s iGaming operations, while monetizing legacy biotech IP.
Thiel’s investor group now has stakes in two Ethereum treasury companies. In mid-July, he reported holding over 9% of Tom Lee’s BitMine Immersion, currently the biggest corporate ETH holder with close to $5 billion in its treasury.